$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Pulmonary administration of granulocyte colony stimulating factor 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/14
  • A61K-045/05
  • C07K-017/10
  • C07K-015/14
출원번호 US-0953208 (1992-09-29)
발명자 / 주소
  • Platz Robert M. (Half Moon Bay CA) Winters Mark A. (Mountain View CA) Pitt Colin G. (Thousand Oaks CA)
출원인 / 주소
  • Amgen Inc. (Thousand Oaks CA 02)
인용정보 피인용 횟수 : 189  인용 특허 : 0

초록

Granulocyte-colony stimulating factor (G-CSF) can be delivered systemically in therapeutically or prophylactically effective amounts by pulmonary administration using a variety of pulmonary delivery devices, including nebulizers, metered dose inhalers and powder inhalers. Aerosol administration in a

대표청구항

A method for the pulmonary administration of G-CSF to a mammal, comprising directing a neutrophil stimulating amount of G-CSF into the oral cavity of the mammal while the mammal is inhaling for those is need thereof.

이 특허를 인용한 특허 (189)

  1. McCarty, Nael; Fuller, Matthew; Kubanek, Julia, ABC transporter ligand GATX1.
  2. Tsai, Li-Huei; Pan, Ling; Haggarty, Stephen J.; Patnaik, Debasis, Activators of class I histone deacetlyases (HDACS) and uses thereof.
  3. Tsai, Li-Huei; Pan, Ling; Haggarty, Stephen J.; Patnaik, Debasis, Activators of class I histone deacetlyases (HDACs) and uses thereof.
  4. B?ckstr?m, Kjell; Dahlb?ck, Magnus; Johansson, Ann; K?llstrand, G?ran; Lindqvist, Elisabet, Aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides.
  5. Backstrom, Kjell; Dahlback, Magnus; Johansson, Ann; Kallstrand, Goran; Lindqvist, Elisabet, Aerosol formulations of peptides and proteins.
  6. Podack, Eckhard R.; Rosenblatt, Joseph D.; Yamazaki, Koichi, Allogeneic cancer cell-based immunotherapy.
  7. Penninger, Josef M.; Kroemer, Guido P.; Siderovski, David Peter; Zamzami, Naoufal; Susin, Santos A.; Snow, Bryan E. L., Apoptosis-inducing factor.
  8. Penninger,Josef M.; Kroemer,Guido P.; Siderovski,David Peter; Zamzami,Naoufal; Susin,Santos A.; Snow,Bryan E. L., Apoptosis-inducing factor.
  9. Chen, Lieping, B7-DC variants.
  10. Chen, Lieping, B7-DC variants immunogenic compositions and methods of use thereof.
  11. Chen, Lieping, B7-DC variants immunogenic compositions and methods of use thereof.
  12. Chen, Lieping; Strome, Scott E.; Kwon, Eugene D., B7-H1 and methods of diagnosis, prognosis, and treatment of cancer.
  13. Chen, Lieping, B7-H1 antibodies and method of use.
  14. Langermann, Solomon; Liu, Linda; Podojil, Joseph R.; Miller, Stephen D.; Marshall, Shannon, B7-H4 fusion proteins and methods of use thereof.
  15. Langermann, Solomon; Liu, Linda; Podojil, Joseph R.; Miller, Stephen D.; Marshall, Shannon, B7-H4 fusion proteins and methods of use thereof.
  16. Banerjee, Partha S.; Chaudry, Imtiaz A.; Pham, Stephen, Bronchodilating Beta-agonist compositions and methods.
  17. Banerjee, Partha S.; Chaudry, Imtiaz A.; Pham, Stephen, Bronchodilating beta-agonist compositions and methods.
  18. Chaudry, Imtiaz A.; Pham, Stephen; Banerjee, Partha S., Bronchodilating β-agonist compositions and methods.
  19. Myc, Andrzej; Kryczek, Ilona; Baker, Jr., James R., Cancer vaccine compositions and methods of using the same.
  20. Brown, Tracey J., Composition and method for the enhancement of the efficacy of drugs.
  21. Holoshitz, Joseph; Ling, Song; Pi, Xiujun; de Almeida, Denise; Gilon, Chaim; Hoffman, Amnon, Compositions and methods for inducing an immune response.
  22. Holoshitz, Joseph; Ling, Song; Pi, Xiujun; de Almeida, Denise; Gilon, Chaim; Hoffman, Amnon, Compositions and methods for inducing an immune response.
  23. Walker, Kenneth W.; Gegg, Jr., Colin V., Compositions and methods for producing bioactive fusion proteins.
  24. Carter, Darryl L., Compositions and methods for reducing the risk of preeclampsia.
  25. Carter, Darryl, Compositions and methods for reducing the risk of preterm labor.
  26. Kung, Andrew; Banerjee, Pallab, Compositions for detecting cell death and methods of use thereof.
  27. Bäckström, Kjell Göran Erik; Dahlbäck, Carl Magnus Olof; Edman, Peter; Johansson, Ann Charlotte Birgit, Compositions for inhalation.
  28. Backstrom, Kjell Goran Erik; Dahlback, Carl Magnus Olof; Edman, Peter; Johansson, Ann Charlotte Birgit, Compositions for inhalation.
  29. Langermann, Solomon; Liu, Linda, Compositions of PD-1 antagonists and methods of use.
  30. Jung, Edward K. Y.; Levien, Royce A.; Lord, Robert W.; Malamud, Mark A.; Rinaldo, Jr., John D.; Wood, Jr., Lowell L., Computational and/or control systems and methods related to nutraceutical agent selection and dosing.
  31. Jung, Edward K. Y.; Levien, Royce A.; Lord, Robert W.; Malamud, Mark A.; Rinaldo, Jr., John D.; Tegreene, Clarence T.; Wood, Jr., Lowell L., Computational systems and methods related to nutraceuticals.
  32. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P.; Nguyen, Hung Q.; Walker, Kenneth W.; Hu, Shaw-Fen Sylvia; Gegg, Jr., Colin V.; Khare, Taruna Arora; Adler, Beverly S.; Martin, Francis H., Conjugated toxin peptide therapeutic agents.
  33. Chen, Lieping; Strome, Scott E.; Kwon, Eugene D., Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target.
  34. Holson, Edward; Lazzaro, Fanny; Olson, David; Wagner, Florence Fevrier; Weiwer, Michel, Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors.
  35. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P.; Nguyen, Hung Q.; Walker, Kenneth W.; Hu, Shaw-Fen Sylvia; Gegg, Jr., Colin V., DNA encoding OSK1 toxin peptide analogs and vectors and cells for combinant expression.
  36. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P.; Nguyen, Hung Q.; Walker, Kenneth W.; Hu, Shaw-Fen Sylvia; Gegg, Jr., Colin V.; Arora Khare, Taruna; Adler, Beverly S.; Martin, Francis H., DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression.
  37. Pardoll, Drew M.; Tsuchiya, Haruo; Gorski, Kevin S.; Tseng, Su-Yi, Dendritic cell co-stimulatory molecules.
  38. Pardoll, Drew M.; Tsuchiya, Haruo; Gorski, Kevin S.; Tseng, Su-Yi, Dendritic cell co-stimulatory molecules.
  39. Chen, Lieping, Detection and diagnosis of inflammatory disorders.
  40. Chen, Lieping, Detection and diagnosis of inflammatory disorders.
  41. Dellamary,Luis A.; Tarara,Thomas E.; Kabalnov,Alexey; Weers,Jeffry G.; Schutt,Ernest G., Dispersion for pulmonary delivery of a bioactive agent.
  42. Tarara, Thomas E.; Weers, Jeffry G.; Kabalnov, Alexey; Schutt, Ernest G.; Dellamary, Luis A., Engineered particles and methods of use.
  43. Tarara,Thomas E.; Weers,Jeffry G.; Kabalnov,Alexey; Schutt,Ernest G.; Dellamary,Luis A., Engineered particles and methods of use.
  44. Duliege, Anne-Marie; Stead, Richard; Leuther, Kerstin; Woodburn, Kathryn Wynne; Naso, Robert Barnett, Erythropoietin receptor peptide formulations and uses.
  45. Tarara, Thomas E.; Weers, Jeffry G.; Eldon, Michael A.; Narashimhan, Rangachari; Clark, Andrew, Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use.
  46. Podack, Eckhard R.; Rosenblatt, Joseph R., Heat shock protein GP96 vaccination and methods of using same.
  47. Sanberg,Paul R.; Engelman,Robert W.; Gower,William R., Human immunosuppressive protein.
  48. Brown, Tracey J., Hyaluronan as a chemo-sensitizer in the treatment of cancer.
  49. Brown, Tracey J.; Fox, Richard M., Hyaluronan as a drug pre-sensitizer and chemo-sensitizer in the treatment of disease.
  50. Brown, Tracey J., Hyaluronan-chemotherapeutic agent formulations for the treatment of colon cancer.
  51. Uhlmann, Eugen; Debelak, Harald; Jurk, Marion; Weber, Markus, Immune stimulatory oligonucleotide analogs containing modified sugar moieties.
  52. Cox, John Cooper; Drane, Debbie Pauline; Suhrbier, Andreas, Immunogenic complexes and methods relating thereto.
  53. Cox, John Cooper; Drane, Debbie Pauline; Suhrbier, Andreas, Immunogenic complexes and methods relating thereto.
  54. Jung, Edward K. Y.; Levien, Royce A.; Lord, Robert W.; Malamud, Mark A.; Rinaldo, Jr., John D.; Wood, Lowell L., Individualized pharmaceutical selection and packaging.
  55. Holson, Edward; Wagner, Florence Fevrier; Weiwer, Michel; Haggarty, Stephen J.; Zhang, Yan-Ling, Inhibitors of histone deacetylase.
  56. Rubsamen Reid M., Intrapulmonary delivery of hematopoietic drug.
  57. Ann L. Daugherty, Intrapulmonary delivery of polypeptide growth factors and cytokines.
  58. Choi-Sledeski, Yong Mi; Choy, Nakyen; Poli, Gregory B.; Shay, Jr., John J.; Shum, Patrick Wai-Kwok; Sledeski, Adam W., Method and intermediates for the preparation of 2,2,2-trifluoro-N-(4-fluoro-3-pyridin-4-yl-benzyl)-acetamide hydrochloride.
  59. Carter, Darryl, Method for identifying a patient at risk of having difficulty in sustaining a pregnancy.
  60. Carter, Darryl, Method for reducing the likelihood of implantation failure during an assisted reproduction in a subject in need thereof.
  61. Carter, Darryl, Method for reducing the likelihood of spontaneous abortion presenting a sign or symptom of threatened abortion.
  62. Carter, Darryl L., Method for reducing the risk of spontaneous abortion in a human female subject.
  63. Carter,Darryl, Method of reducing the likelihood of implantation failure during an assisted reproduction in a female subject in a need thereof.
  64. Dieckgraefe,Brian K.; Korzenik,Joshua, Method of treating Crohn's Disease using sargramostim.
  65. Condos, Rany; Rom, William; Smaldone, Gerald, Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-γ.
  66. Condos, Rany; Smaldone, Gerald, Method of treating tuberculosis with interferons.
  67. Condos, Rany; Smaldone, Gerald, Method of treating tuberculosis with interferons.
  68. Hinderer, Walter; Lubenau, Heinz, Method of treatment using stable liquid formulation of G-CSF.
  69. Patton, John S.; Foster, Linda S.; Platz, Robert M., Methods and compositions for pulmonary delivery of insulin.
  70. Platz Robert M. ; Kimura Shigenobu,JPX ; Satoh Yu-ichiro,JPX ; Foster Linda C., Methods and compositions for the dry powder formulation of interferons.
  71. Robert M. Platz ; Shigenobu Kimura JP; Yu-ichiro Satoh JP; Linda C. Foster, Methods and compositions for the dry powder formulation of interferons.
  72. Langermann, Solomon; Liu, Linda, Methods and compositions for the inhibition of transplant rejection.
  73. Matrajt, Mariana L.; Angel, Sergio O.; Echeverria, Pablo C., Methods and compositions for treating .
  74. Dong, Haidong; Kwon, Eugene D.; Markovic, Svetomir N.; Krco, Christopher J., Methods and materials for treating cancer.
  75. Cohen, Charles; Kumar, Krishna; Doyle, Jamie Raudensky; Kopin, Alan S., Methods and systems for designing and/or characterizing soluble lipidated ligand agents.
  76. Jung, Edward K. Y.; Levien, Royce A.; Lord, Robert W.; Malamud, Mark A.; Rinaldo, Jr., John D.; Tegreene, Clarence T.; Wood, Jr., Lowell L., Methods and systems related to receiving nutraceutical associated information.
  77. Jung, Edward K. Y.; Levien, Royce A.; Lord, Robert W.; Malamud, Mark A.; Rinaldo, Jr., John D.; Tegreene, Clarence T.; Wood, Jr., Lowell L., Methods and systems related to transmission of nutraceutical associated information.
  78. Yan, Wei; Wittekind, Michael; Forte, Carla, Methods for generating monovalent IgG.
  79. McCarty, Neal; Thompson, Christopher H.; Kubanek, Julia, Methods for inhibiting CLC-2 channel with GATX2.
  80. Carter, Darryl L., Methods for reducing the risk of an unsuccessful pregnancy in a subject having an immune system abberation.
  81. Carter, Darryl L., Methods for reducing the risk of spontaneous abortion in a human female comprising administering an effective amount of G-CSF.
  82. Dong, Haidong; Harrington, Susan M.; Kwon, Eugene D.; Krco, Christopher J.; Liu, Xin, Methods for treating cancer in patients with elevated levels of BIM.
  83. Pelleymounter, Mary Ann; Toombs, Christopher Francis; Mann, Michael Benjamin, Methods of increasing lean tissue mass using OB protein compositions.
  84. Pelleymounter,Mary Ann; Toombs,Christopher Francis; Mann,Michael Benjamin, Methods of increasing lean tissue mass using OB protein compositions.
  85. Hinderer, Walter; Lubenau, Heinz, Methods of preparing a liquid formulation of G-CSF.
  86. Carter, Darryl, Methods of reducing the likelihood of spontaneous abortion.
  87. Tarara, Thomas E.; Weers, Jeffry G.; Kabalnov, Alexey; Schutt, Ernest G.; Dellamary, Luis A., Methods of spray drying pharmaceutical compositions.
  88. Pardoll, Drew M.; Tsuchiya, Haruo; Gorski, Kevin S.; Tseng, Su-Yi, Methods of using B7-DC molecules to induce or enhance an immune response.
  89. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P., Methods of using OSK1 peptide analogs.
  90. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  91. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  92. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  93. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  94. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  95. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  96. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  97. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  98. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  99. Gegg,Colin; Xiong,Fei; Sitney,Karen C., Modified Fc molecules.
  100. Feige,Ulrich, Modified peptides as therapeutic agents.
  101. Feige,Ulrich, Modified peptides as therapeutic agents.
  102. Friedman, Jeffrey M.; Zhang, Yiying; Proenca, Ricardo, Modulators of body weight, corresponding nucleic acids and proteins.
  103. Friedman Jeffrey M. ; Zhang Yiying ; Proenca Ricardo, Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof.
  104. Baker, James R.; Rathinavelu, Sivaprakash; Makidon, Paul E.; LiPuma, John J.; Nigavekar, Shraddha, Nanoemulsion therapeutic compositions and methods of using the same.
  105. Baker, Jr., James R.; Hemmila, Mark R.; Wang, Stewart C.; Hamouda, Tarek; LiPuma, John J.; Knowlton, Jessica A.; Makidon, Paul E.; Blanco, Luz P.; Groom, II, Jeffery V.; Bielinska, Anna U., Nanoemulsion therapeutic compositions and methods of using the same.
  106. Baker, Jr., James R.; Hemmila, Mark R.; Wang, Stewart C.; Hamouda, Tarek; LiPuma, John J.; Knowlton, Jessica Ann; Makidon, Paul E.; Blanco, Luz; Groom, II, Jeffery V.; Bielinska, Anna U., Nanoemulsion therapeutic compositions and methods of using the same.
  107. Baker, Jr., James R.; Rathinavelu, Sivaprakash; Makidon, Paul E.; LiPuma, John J.; Nigavekar, Shraddha, Nanoemulsion therapeutic compositions and methods of using the same.
  108. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Miller, Michelle; Bulock, Karen G., Neutral nanotransporters.
  109. Chen, Lieping, Nucleic acid molecules encoding B7-DC variants.
  110. Friedman Jeffrey M. ; Zhang Yiying ; Proenca Ricardo ; Maffei Margherita, Nucleic acid primers and probes for the mammalian OB gene.
  111. Friedman, Jeffrey M.; Zhang, Yiying; Proenca, Ricardo; Maffei, Margherita; Halaas, Jeffrey L.; Gajiwala, Ketan; Burley, Stephen K., Nucleic acids encoding modulators of body weight.
  112. Mann, Michael B.; Hecht, Randy Ira; Pelleymounter, Mary Ann; Toombs, Christopher Francis, OB fusion protein compositions and methods.
  113. Mann,Michael B.; Hecht,Randy Ira; Pelleymounter,Mary Ann; Toombs,Christopher Francis, OB fusion protein compositions and methods.
  114. Friedman Jeffrey M. ; Zhang Yiying ; Proenca Ricardo, OB polypeptide antibodies and method of making.
  115. Jeffrey M. Friedman ; Yiying Zhang ; Ricardo Proenca, OB polypeptides and modified forms as modulators of body weight.
  116. Friedman Jeffrey M. ; Zhang Yiying ; Proenca Ricardo, OB polypeptides as modulators of body weight.
  117. Friedman Jeffrey M. ; Zhang Yiying ; Proenca Ricardo, OB polypeptides, modified forms and compositions.
  118. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P., OSK1 peptide analogs and pharmaceutical compositions.
  119. Jeffrey M. Friedman ; Yiying Zhang ; Ricardo Proenca, Ob polypeptides, modified forms and compositions thereto.
  120. Min,Hosung; Sitney,Karen C.; Hartley,Cynthia, Peptides and related compounds having thrombopoietic activity.
  121. Uhlmann, Eugen; Jürk, Marion, Phosphate-modified oligonucleotide analogs with enhanced immunostimulatory activity.
  122. Weers, Jeffry G.; Tarara, Thomas E.; Dellamary, Luis A.; Riess, Jean G.; Schutt, Ernest G., Phospholipid-based powders for drug delivery.
  123. Weers, Jeffry G; Tarara, Thomas E; Dellamary, Luis A; Riess, Jean G; Schutt, Ernest G, Phospholipid-based powders for drug delivery.
  124. Weers,Jeffry G.; Tarara,Thomas E.; Dellamary,Luis A.; Riess,Jean G.; Schutt,Ernest G., Phospholipid-based powders for drug delivery.
  125. Tuomanen, Elaine I.; Wizemann, Theresa M.; Masure, H. Robert; Johnson, Leslie Sydnor; Koenig, Scott, Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof.
  126. Tuomanen,Elaine I.; Wizemann,Theresa M.; Masure,H. Robert; Johnson,Leslie S.; Koenig,Scott, Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof.
  127. Backstrom Kjell,SEX ; Johansson Ann,SEX ; Linden Helena,SEX, Powder formulations containing melezitose as a diluent.
  128. Backstrom Kjell Goran Erik,SEX ; Dahlback Carl Magnus Olof,SEX ; Edman Peter,SEX ; Johansson Ann Charlotte Birgit,SEX, Processes for preparing compositions for inhalation.
  129. Patton,John S., Pulmonary delivery of active fragments of parathyroid hormone.
  130. Tarara, Thomas E.; Weers, Jeffry G.; Venthoye, Geraldine, Pulmonary delivery of aminoglycoside.
  131. Tarara, Thomas E; Weers, Jeffry G; Venthoye, Maria Geraldine, Pulmonary delivery of aminoglycoside.
  132. Tarara,Thomas E.; Weers,Jeffry G.; Venthoye,Geraldine, Pulmonary delivery of aminoglycosides.
  133. Tarara, Thomas E.; Weers, Jeffrey G.; Kabalnov, Alexey; Schutt, Ernest G.; Dellamary, Luis A., Pulmonary delivery particles comprising an active agent.
  134. Blacklow, Stephen; Fisher, Carl; Estrada, Kristine, RAP variants for drug delivery and methods of use thereof.
  135. Woolf, Tod M.; Kamens, Joanne; Salomon, William; Khvorova, Anastasia, RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality.
  136. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Cardia, James, Reduced size self-delivering RNAi compounds.
  137. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Cardia, James, Reduced size self-delivering RNAi compounds.
  138. Weers, Jeffry G.; Schutt, Ernest G.; Dellamary, Luis A.; Tarara, Thomas E.; Kabalnov, Alexey, Respiratory dispersion for metered dose inhalers comprising perforated microstructures.
  139. Czerkinsky, Cecil; Kim, Dong Wook, Shigella protein antigens and methods.
  140. Roser, Bruce J.; Colaco, Camilo; Jerrow, Mohammed A. Z.; Blair, Julian; Kampinga, Jaap; Wardell, James Lewis; Duffy, John Alistair, Solid delivery systems for controlled release of molecules incorporated therein and methods of making same.
  141. Roser Bruce J.,GBX ; Kampinga Jaap,NLX ; Colaco Camilo,GBX ; Blair Julian,GBX, Solid dose delivery vehicle and methods of making same.
  142. Roser Bruce J.,GBX ; Kampinga Jaap,NLX ; Colaco Camilo,GBX ; Blair Julian,GBX, Solid dose delivery vehicle and methods of making same.
  143. Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
  144. Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
  145. Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
  146. Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
  147. Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
  148. Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
  149. Roser,Bruce J.; Kampinga,Jaap; Colaco,Camilo; Blair,Julian, Solid dose delivery vehicle and methods of making same.
  150. Dellamary,Luis A.; Tarara,Thomas; Kabalnov,Alexey; Weers,Jeffry; Schutt,Ernest, Stabilized bioactive preparations and method of use.
  151. Luis A. Dellamary ; Thomas E. Tarara ; Alexey Kabalnov ; Jeffry G. Weers ; Ernest G. Schutt, Stabilized bioactive preparations and methods of use.
  152. Weers, Jeffry G.; Schutt, Ernest G.; Dellamary, Luis A.; Tarara, Thomas E.; Kabalnov, Alexey, Stabilized preparation for use in metered dose inhalers.
  153. Weers Jeffry G. ; Schutt Ernest G. ; Dellamary Luis A. ; Tarara Thomas E. ; Kabalnov Alexey, Stabilized preparations for use in metered dose inhalers.
  154. Weers, Jeffry G.; Schutt, Ernest G.; Dellamary, Luis; Tarara, Thomas E.; Kabalnov, Alexey, Stabilized preparations for use in metered dose inhalers.
  155. Schutt, Ernest G.; Tarara, Thomas E.; Dellamary, Luis A.; Kabalnov, Alexey; Weers, Jeffry G., Stabilized preparations for use in nebulizers.
  156. Hinderer, Walter; Lubenau, Heinz, Stable liquid formulations of G-CSF.
  157. Dellamary, Luis A.; Reiss, Jean; Schutt, Ernest G.; Weers, Jeffry G.; Tarara, Thomas E., Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery.
  158. Dellamary, Luis A.; Riess, Jean; Schutt, Ernest G.; Weers, Jeffry G.; Tarara, Thomas E., Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use.
  159. Dellamary, Luis A; Riess, Jean; Schutt, Ernest G; Weers, Jeffry G; Tarara, Thomas E, Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use.
  160. Podobnik, Barbara; Gaberc Porekar, Vladka; Menart, Viktor, Stable pharmaceutical composition granulocyte-colony stimulating factor.
  161. Brian Dieckgraefe ; Joshua Korzenik, Stimulating neutrophil function to treat inflammatory bowel disease.
  162. Dieckgraefe, Brian K.; Korzenik, Joshua, Stimulating neutrophil function to treat inflammatory bowel disease.
  163. Dieckgraefe,Brian K.; Korzenik,Joshua, Stimulating neutrophil function to treat inflammatory bowel disease.
  164. Podobnik, Barbara; Porekar, Vladka Gaberc; Menart, Viktor, Surfactant-free stable pharmaceutical composition comprising granulocyte-colony stimulating factor.
  165. B?ckstr?m, Kjell G?ran Erik; Dahlb?ck, Carl Magnus Olof; Edman, Peter; Johansson, Ann Charlotte Birgit, Systemic administration of a therapeutic preparation.
  166. Backstrom Kjell Goran Erik,SEX ; Dahlback Carl Magnus Olof,SEX ; Edman Peter,SEX ; Johansson Ann Charlotte Birgit,SEX, Systemic administration of a therapeutic preparation.
  167. Jung, Edward K. Y.; Leuthardt, Eric C.; Levien, Royce A.; Lord, Robert W.; Malamud, Mark A.; Rinaldo, Jr., John D.; Wood, Jr., Lowell L., Systems and methods for transmitting pathogen related information and responding.
  168. Blander, Julie Magarian; Torchinsky, Miriam, T-helper cell type 17 lineage-specific adjuvants, compositions and methods.
  169. Blander, Julie Magarian; Torchinsky, Miriam, T-helper cell type 17 lineage-specific adjuvants, compositions and methods.
  170. Brown, Tracey J.; Brownlee, Gary R., Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment.
  171. Walker, Kenneth W.; Kinstler, Olaf B.; Sitney, Karen C., Therapeutic peptides.
  172. Backstrom Kjell Goran Erik,SEX ; Dahlback Carl Magnus Olof,SEX ; Edman Peter,SEX ; Johansson Ann Charlotte Birgit,SEX, Therapeutic preparation for inhalation.
  173. Backstrom Kjell Goran Erik,SEX ; Dahlback Carl Magnus Olof,SEX ; Edman Peter,SEX ; Johansson Ann Charlotte Birgit,SEX, Therapeutic preparation for inhalation.
  174. Backstrom Kjell Goran Erik,SEX ; Dahlback Carl Magnus Olof,SEX ; Edman Peter,SEX ; Johansson Ann Charlotte Birgit,SEX, Therapeutic preparation for inhalation.
  175. Backstrom, Kjell Goran Erik; Dahlback, Carl Magnus Olof; Edman, Peter; Johansson, Ann Charlotte Birgit, Therapeutic preparation for inhalation.
  176. Kjell Backstrom SE; Bjorn Wallmark DE; Magnus Dahlback SE; Peter Edman SE; Ann Johansson SE, Therapeutic preparations for inhalation.
  177. Brown, Tracey J., Therapeutic protocols using hyaluronan.
  178. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  179. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  180. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  181. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  182. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  183. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  184. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  185. Min, Hosung; Walker, Kenneth W.; Gegg, Colin V.; Galimi, Francesco; Sun, Jeonghoon; Tsai, Mei-Mei, Thrombopoietic compounds.
  186. Min, Hosung; Walker, Kenneth W.; Gegg, Jr., Colin V.; Galimi, Francesco; Sun, Jeonghoon; Tsai, Mei-Mei, Thrombopoietic compounds.
  187. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P.; Nguyen, Hung Q.; Walker, Kenneth W.; Hu, Shaw-Fen Sylvia; Gegg, Colin V.; McDonough, Stefan I., Toxin peptide therapeutic agents.
  188. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P.; Nguyen, Hung Q.; Walker, Kenneth W.; Hu, Shaw-Fen Sylvia; Gegg, Colin V.; McDonough, Stefan I., Toxin peptide therapeutic agents.
  189. Choi-Sledeski, Yong Mi; Choy, Nakyen; Poli, Gregory Bernard; Shay, Jr., John J.; Shum, Patrick Wai-Kwok; Sledeski, Adam W., [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-flouro-1-(2-methoxy-ethyl)-4-trifluorom as an inhibitor of mast cell tryptase.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로